Norton Lilly Case Review

In: Business and Management

Submitted By Dachance13
Words 881
Pages 4
Norton Lilly International: Written Case Norton Lilly is an international shipping agency. They have 37 regional offices, which provided service to ships in 70 ports located in North America, Caribbean, Pacific, and the Middle East. Their services consist of booking freight for export, clearing inbound cargo with U.S. customs, fueling vessels, restocking vessels with supplies and provisions, and arranging cargo-handling services. The company started way back in 1841, 150 years ago to this case’s time period, starting with John Norton. In 1907, the company expanded to include the Lilly family. In 1925, the company expanded to become international, with the opening of a Norton Lilly office in Panama. In 2010, Norton Lilly is the market share leader. 1
Norton Lilly has been successful as a company for their entire 150 years of existence. This is an achievement by itself. Most companies are not continually successful for more than a decade, with economies, struggle to compete, technology advancements, and leadership/ownership. The one thing that stands out about Norton Lilly is the overpowering emphasis on having successful leadership in the company. When Norton Lilly slowed and had a $2.6 million net loss in 2006, they looked at what had been successful, and because of outside acquisitions of agencies, a lack of focus on bottom-line performance, and a poor focus on operational performance, they began a turnaround. Starting with good leaders, Norton Lilly used an executive board of 9 to spread a new, focused strategy of overall performance, and utilized these committee members as the leaders for their regions.
Norton Lilly, however, has some downfalls. Because of the new emphasis of a “balanced scorecard” and “KPI”, the performance needed to be tracked, and with there being over 37 regional offices and 70 ports, interference was prevalent. Tracking…...

Similar Documents

Case Review

...Transformational change in organisations: a self-regulation approach Transformational change in organisations 143 Purpose – The purpose of the present paper is to advance a testable model, rooted on well-established control and self-regulation theory principles, explaining the causal links between change-related sensemaking, interpretation, readiness and subsequent behavioural action. Design/methodology/approach – Following a review of the two motivation theories and clarification of change-related sensemaking, interpretation, and readiness concepts, the paper proposes a series of research propositions (illustrated by a conceptual model) clarifying how these concepts interact with self-regulating mechanisms. In addition, the feedback model exemplifies how cognitive processes triggered by new knowledge structures relate to behavioural action. Findings – The model expands upon other existing frameworks by allowing the examination of multi-level factors that account for, and moderate causal links between, change-related sensemaking, interpretation, readiness, and behavioural action. Suggestions for future research and guidelines for practice are outlined. Practical implications – The variables and processes depicted in the model provide guidelines for change management in organisations, both for individuals and for groups. By eliciting important self-regulating functions, change agents will likely facilitate sensemaking processes, positive interpretations of change, change...

Words: 9992 - Pages: 40

Elli Lilly Case

...Parinaz Kokabi OP 300 “Elli Lilly and the Company: The Flexible Facility Decision” case analysis Due to the fierce competition in pharmaceutical industry, Elli Lily has to change its product development process to retain its situation in the market. Steve Mueller, manager of strategic facilities planning, must suggest the company what type of manufacturing facilities to construct. These new facilities were needed for three new products (Alfatine, Betazin, and Clorazin), which the company expected to launch in 1996. His decision will be based on decreasing the lead-time by 50% and reducing the costs by 25%. According to the case, Mueller suggest three options: one option is to build one specialized facility; the second option is to build one flexible facility, and the third options which is stated under the second option is a combination of specialized and flexible facility. The first choice, building a specialized facility, will not reduce the production lead-time. In addition, since the facility is built only for one type of product, if that product cannot be launched to the market the part of the facility might have to be retrofitted to produce another product. Further, it can cause delays in production, which can cost the company millions of dollars in loss. However, this option is very productive (almost 16,000 kilograms of output per rig at 80% of utilization) because the plant is dedicated to a set of special products and there is no changeover. ......

Words: 589 - Pages: 3

Norton Lilly

...Beginning in 1841, John Norton booked a shipment of kerosene aboard a small sailing ship bound for South America. Little did he know this would be the start of an international shipping company that is still around today over 150 years later. Norton Lilly International provides services to ships in 70 ports located in North America, the Caribbean, the Pacific and the Middle East. The company had experienced rapid growth due to the development of cargo containerization. By 2005, the company had experienced annual revenues of more than $41 million and was the largest privately held shipping agency based in North America. In 2006 everything changed and the company had a net loss of $2.6 million. A failure to effectively integrate acquired shipping agencies, an inadequate attention to operational performance and too little focus on bottom-line performance all contributed to the company being in this unfamiliar position. Jim Burton became CFO in 2007 to turn everything around. Burton was expected to develop a sustainable business platform that would be capable of doubling the company’s size and generating an attractive return on investment. Jim Burton did everything in his power to help turn around Norton Lilly International. Due to the fact that he was new to this industry and dealing with veterans that had 30 years of experience he had to use an incremental approach by introducing ideas and building on them once accepted. He formed an executive committee in order to......

Words: 996 - Pages: 4

Norton Lilly

...Slide 1 The Norton Lilly International Vision is to: achieve sustainable growth while remaining the premier shipping agency in the Americas. We will accomplish this through our commitment to providing quality service to our customers and creating a motivated and dedicated workplace, utilizing the latest in technologies.   Slide 2 Since 1841, Norton Lilly has operated and transformed their shipping industry through various port agency services. The various services include booking freight for export, clearing inbound cargo with U.S. Customs, fueling vessels, restocking vessels with supplies and provisions, and arranging cargo handling services Slide 3 The Norton Lilly company did have humble beginnings of shipping kerosene to expanding and becoming the “market share leader in handling Panama Canal transits in 2010” (bk pg C369). From 1970s to 2000, the company experienced great growth potential. However also experienced were some setbacks following those years of steady growth. 2006 brought Norton Lilly in the negative of (2.6M) but gradually began climbing to a profit by 2009 with a net income of 3M. By 2010, generated revenue reached 6.3M. Slide 4 Revenues have fluctuated over the past five years. If we are wanting to expand operations, we need to see steady increases in revenues. Cost of revenues remains statistically the same, which means we can’t cut expenses from it. Where we are cutting expenses is in our loss from disposal of assets and investments,......

Words: 952 - Pages: 4

Norton Lilly

...the case and identify lessons for future management practice. Design/methodology/approach – Some of the fundamental principles of issue management, post-crisis discourse and corporate apologia are to recognize the problem early, to promptly institute a strategic response plan and corrective action and, if necessary, to apologise genuinely and without delay. The paper assesses the case against the theoretical basis of each of these principles and comparable cases. A senior executive of the company concerned was interviewed about some management aspects. Findings – Despite early indications of a problem which had potential impact around the world, a major global corporation responded inadequately to a local situation and, as a result, suffered prolonged embarrassment at the hands of two teenagers and unnecessarily severe damage to its brand and international reputation. Originality/value – By in-depth analysis of a recent case, the paper underlines valuable lessons in terms of prompt management intervention, consistent strategy and effective apologia. It also illustrates the danger of poor management of a brand extension and the risk of contagion facing multinational organizations where adverse outcomes in one small regional market can rapidly damage a global reputation. Keywords Brand image, Corporate image, Corporate strategy, Complaints, Advertising Paper type Case......

Words: 2893 - Pages: 12

Review Case

...1. Report shown the probability of cases being appealed and reversed in three different courts Court | Total Cases Disposed | Appealed Case | Reversed Case | Probability of cases being appealed and reversed in three different courts | Common Pleas Court | 43945 | 1762 | 199 | 0.01 | Domestic Relations Court | 30499 | 106 | 17 | 0.01 | Municipal Court | 108464 | 500 | 104 | 0.01 | | | | | Question 2 | Question 3 | Question 4 | Question 5 | List of Judges | Total Cases Disposed | Appealed Case (A) | Reversed Case (B) | Probability of a case being appealed for each judge P(A) | Probability of a case being reversed for each judge P(B) | Probability of reversal given an appeal for each judge P(B|A) | Ranking of the judge who has the least Probability of a case being appealed for each judge P(A) | Fred Cartolano | 3037 | 137 | 12 | 0.0451 | 0.0040 | 0.0876 | 36 | Thomas Crush | 3372 | 119 | 10 | 0.0353 | 0.0030 | 0.0840 | 26 | Patrick Dinkelacker | 7259 | 63 | 12 | 0.0087 | 0.0017 | 0.1905 | 23 | Timothy Hogan | 4262 | 73 | 9 | 0.0171 | 0.0021 | 0.1233 | 24 | Rober Kraft | 3138 | 127 | 7 | 0.0405 | 0.0022 | 0.0551 | 32 | William Mathews | 2264 | 91 | 18 | 0.0402 | 0.0080 | 0.1978 | 29 | William Morrissey | 3032 | 121 | 22 | 0.0399 | 0.0073 | 0.1818 | 28 | Norber Nadel | 2959 | 131 | 20 | 0.0443 | 0.0068 | 0.1527 | 35 | Arthur Ney, Jr. | 3219 | 125 | 14 | 0.0388 | 0.0043 | 0.1120 | 27 | Richard Niehaus | 3353 | 137 | 16 |......

Words: 816 - Pages: 4

Eli Lilly Case

...Eli Lilly is a leading pharmaceutical company located in Indianapolis, Indiana, which specializes in treatment of several high profile diseases. Evista, a newly developed drug by Eli Lilly, is an estrogen replacement therapy medicine for prevention of osteoporosis which through testing has seemed to lower the incidence of breast cancer in women. This FDA approved drug is expected to be a potential blockbuster and generate revenue of 1 billion US dollars per year for the company. Pharmaceuticals is a highly competitive market and it is imperative for the leading companies to recuperate their development costs and generate returns for stockholders as well as fund research and development for potential new drugs at almost a constant rate. With the profitable lifetime for drugs, in United States, being significantly shortened since the 1980’s, Lilly Research Laboratories was able to develop Evista in a much shorter time period by adopting a Matrix-Based development approach and utilizing heavyweight teams. This strayed from their usual path of function-based product development strategy. With the possibility of profound profits from the commercialization of Evista, Dr. Gus Watanabe has to weigh whether the increasing internal resistance to heavyweight teams and shortage of resources is worth it. Watanabe needs to make a decision about adopting this new successful heavyweight team approach for commercialization of Evista as well as product development. Changes in the past few......

Words: 2988 - Pages: 12

Case Review

...Yeoh Theam Poh & Anor v Bench Win Sdn Bhd & Anor and other suits [2013] 8 MLJ Fact of the case The plaintiffs in the three suits occupied a dwelling(‘the premises’) built on state land that was built by the plaintiff’s father who was given the temporary occupying licence(TOL). The father still dwelling on the premises after the TOL had been cancelled without permission and approval from the state. The first defendant (Bench Win), a housing developer wanted to built an access to the housing project on the premises occupied by the plaintiffs. The compensation agreement was entered between them in separate that in return for the plaintiffs vacant the premises, the second defendant (Archlaw Development) would give them one free and two price-discounted apartments in housing project. The plaintiffs vacated the premises but Bench Win notified the plaintiffs that it was rescinding the compensation agreement as the housing project cannot be implemented for some reason. The plaintiffs filed the instant suits to declare that their compensation agreements with Bench Win and their sale and purchase agreement (SPAs) with Archlaw Development were valid and subsisting. They also sought an order that the SPAs be specifically performed and that they be awarded damages and costs. Bench Win, which only later discovered that the plaintiffs were squatters, pleaded that the consideration for the compensation agreement was illegal and the contract were void. Issues Whether the contact......

Words: 767 - Pages: 4

Eli Lilly Case Study

...Executive Summary With the evolution of the Pharmaceutical industry in the US and the current decline of the blockbuster products of Eli Lilly which were coming to an end of their life cycle, the company is in the process of developing three new products that plan to launch in 1996. A great number of factors such as decrease of the industry growth rate, steady decline of innovation, increasing competition from competitors, generic drug substitutes, government regulations and an ever increasing cost in manufacturing, R&D and quality protocols and processes have made the decision to launch new products into the market place a necessity and created a topic of debate within the management and leadership of the company. In response to these conditions, the management has established a company-wide initiative and goals to accomplish in the launching of their three new upcoming products. These goals were set up keeping in mind that the company wanted to bring new innovative products to their customers faster, cheaper and serving the needs of their customers. 1. Reduce manufacturing costs by 25%. 2. Reduce product development lead time by 50% as compared to the current lead time of 8 to 12 years. 3. Never Stock out – meet projected manufacturing demands. The dilemma facing this company and the upcoming challenge has given rise to a difficult decision by Steve Muller, Manager of Strategic Facilities and Planning at Eli Lily and Company. The decision was to decide on the......

Words: 1959 - Pages: 8

Case 6-3 Eli Lilly in India

...CASE 6-3 “Eli Lilly in India: Rethinking the Joint Venture Strategy” 1. I think Eli Lilly pursued the right strategy joining Ranbaxy Laboratories to enter the Indian market. While companies were using the global market to amortize the huge investments required to produce a new drug, they were hesitant to invest in countries where the intellectual property regime was weak. During the 1990s both companies had a strong reason for the joint venture. Ranbaxy wanted to make its presence globally and Lilly wanted to get their feet on Indian grounds. In 1992, Ranbaxy approached Lilly to investigate the possibility of supplying certain active ingredients or sourcing of intermediate products to Lilly in order to provide low cost sources of intermediate pharmaceutical ingredients. Based on the strategic alliance, Ranbaxy would supply certain products to the joint venture from its own portfolio that were currently being manufactured in India and then formulate and finish some of Lily’s products locally. From the beginning, both companies had a lot in common, they both believed in high ethical standards, technology and innovation, and future of patented products. They created the joint venture with $7.1 million capital and an initial subscribed equity capital of $3 million, with equal contribution from Lilly and Ranbaxy, leading to an equity ownership of 50 percent each. India, with an 800 million population had about 300 million of people that were considered to...

Words: 855 - Pages: 4

Case Review

...Yeoh Theam Poh & Anor v Bench Win Sdn Bhd & Anor and other suits [2013] 8 MLJ Fact of the case The plaintiffs in the three suits occupied a dwelling(‘the premises’) built on state land that was built by the plaintiff’s father who was given the temporary occupying licence(TOL). The father still dwelling on the premises after the TOL had been cancelled without permission and approval from the state. The first defendant (Bench Win), a housing developer wanted to built an access to the housing project on the premises occupied by the plaintiffs. The compensation agreement was entered between them in separate that in return for the plaintiffs vacant the premises, the second defendant (Archlaw Development) would give them one free and two price-discounted apartments in housing project. The plaintiffs vacated the premises but Bench Win notified the plaintiffs that it was rescinding the compensation agreement as the housing project cannot be implemented for some reason. The plaintiffs filed the instant suits to declare that their compensation agreements with Bench Win and their sale and purchase agreement (SPAs) with Archlaw Development were valid and subsisting. They also sought an order that the SPAs be specifically performed and that they be awarded damages and costs. Bench Win, which only later discovered that the plaintiffs were squatters, pleaded that the consideration for the compensation agreement was illegal and the contract were void. Issues Whether the contact void and......

Words: 312 - Pages: 2

Case Analysis: Eli Lilly in India:

...1. Did Eli Lilly pursue the right strategy (i.e., should it have used a joint venture) to enter the Indian market? Why or why not? You should refer to Chapter 6 of the notes for guidance. With the upward trend of globalization, cross-border commercialization has become inherent in business strategies pursuing not only improved competitiveness but to avoid market share erosion. Expanding to new markets, reducing friction with socio-cultural and legal barriers, reduce capital costs, securing raw materials and implementing economies of scale are just a few motivations which to look abroad for and consider the intricacies of operating in another country. Changes in India’s economic policies from an import substitution to an export-driven one, was the legal foundation that allowed Eli Lilly to pursue its interest to market its drugs in India, where it already had relationships with local manufacturers to produce human or animal insulin for the Soviet Union market, but did not for the Indian market (Bartlett & Beamish, 2014, p. 524) The opportunity presented by Ranbaxy, the second largest pharmaceutical company in India, to supply certain active ingredients or intermediate products to formulate and complete Lilly’s, and for the Joint Venture (JV) to sell and distribute those products, was the perfect opportunity to enter a “new” market while sharing the costs and risks with a well-known and respected partner. With the then existing market conditions (Sales turnover caps,......

Words: 863 - Pages: 4

Eli Lilly Case

...------------------------------------------------- Report on ------------------------------------------------- Eli Lilly and Company- ------------------------------------------------- The Flexible Facility Decision ------------------------------------------------- ------------------------------------------------- Course Title ------------------------------------------------- Managerial Written Communication ------------------------------------------------- ------------------------------------------------- Submitted to ------------------------------------------------- Prof. Mukul Vasavada ------------------------------------------------- & ------------------------------------------------- Prof. Nayana Shah ------------------------------------------------- ------------------------------------------------- ------------------------------------------------- Submitted By ------------------------------------------------- Ankush Huddar (04) ------------------------------------------------- ------------------------------------------------- On ------------------------------------------------- 8th December, 2011 ------------------------------------------------- Adani Institute of Infrastructure Management ------------------------------------------------- PGPIM Batch III 2011-2012 ------------------------------------------------- Eli Lilly and Company To: | Chairman,Manufacturing Strategy Committee | From: | Steve......

Words: 1810 - Pages: 8

Eli Lilly Case Study

...University of Maryland Case Study Analysis Eli Lilly: Developing Cymbalta Case Study AMBA 650 Section 1131 Kelvin Harris January 24, 2012 Executive Summary Eli Lilly and Company resounding success was the arrival of Prozac in 1988. By mid-1988, a new anti-depressant team was formed to find and develop a drug that would be the successor to Prozac. The strategic issues and problems they faced were developing a new drug to replace Prozac, meeting the company budget constraints to perform clinical trials, and finally launch the new drug by mid-2001. The analysis and evaluation revealed that the pharmaceutical industry is changing fast and it usually takes a long time and millions of dollars to develop a new drug. The recommendation for Eli Lilly is to take the lead in developing the new drug Cymbalta, invest a stable share of the company revenue, seek the FDA approval for the development of Cymbalta before going to market, and not change their market plan from the FDA approved Cymbalta dosage of 20 mg twice daily. Introduction Eli Lilly and Company was founded by Colonel Eli Lilly, Lilly’s namesake, in 1876 when he purchased a laboratory on Pearl Street in Indianapolis, Indiana. Eli Lilly was a pharmacist who had served in the Union Army during the Civil War. The company success included creating the process for applying gelatin-coating to pills for easier swallowing and the introduction of Iletin which was the first mass-produced insulin. ......

Words: 1938 - Pages: 8

Eli Lilly Case

...Running head: ELI LILLY – DEVELOPING CYMBALTA CASE ANALYSIS 1 Week 4: Eli Libby – Developing Cymbalta Case Analysis Mary Juanita Hawkins University of Maryland University College Author Note This individual assignment was prepared for AMBA650, Section 9245, taught by Professor Philemon O. Oyewole. Introduction Eli Lilly and Company was established on May 10, 1876 in Indianapolis, IN and has been in business more than 132 years. The founder of this pharmaceutical company was Colonel Eli Lilly who was a union army member during the Civil War. This company deals with the development, discovery, sell, and manufacturer of drugs, such as Prozac and integrates supply-chain management within its departments. The first success that the company achieved was the coating of pills using gelatin. In 1923, the company marked another success by introducing Iletin that was used in improving diabetes. This project was the first largest insulin production that the company together with the University of Toronto invented. All through the 1950’s, various advancements were introduced such as the invention of the oral penicillin and the antibiotic known as Erythromycin. Prozac was produced in 1988 and latter succeeded in 1990. In 2000, the drug Zyprexa was utilized in the treatment of schizophrenia and later, the drug Gemzer was introduced for chemotherapy. Before Prozac the treatment available was Tofranil also......

Words: 2475 - Pages: 10